Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

AxoGen Inc

AXGN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Mid Cap Analyst: BUY

Last Close

$48.73

▲ +1.42%

Market Cap $2.62B · Vol 201.87K

Key Metrics

P/E Ratio

N/A

FWD: 79.04

Market Cap

$2.62B

Mid Cap

Div Yield

N/A

Annual dividend

EPS Growth

+58.04%

YoY

RSI (14)

76.93

Momentum

Beta

1.16

vs Market

52W High

$49.90

2.33% below

52W Low

$13.64

257.26% above

Volume

201.87K

Avg 384.74K

P/B

11.99

Price-to-book

ROE

N/A

Return on equity

Free Float

96.28%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, AxoGen Inc (AXGN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AXGN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.95%

+25.69%

+19.00%

+46.64%

YTD

+48.88%

+227.05%

+691.07%

+206.67%

Financials & Valuation

TTM · Annual

Total Revenue	$225.21M
Net Income	$-15,703,000.00
Revenue Growth (YoY)	+23.06%
Gross Margin	74.31%
Operating Margin	-3.49%
Net Profit Margin	-6.97%
ROE	N/A
ROA · ROIC	-7.38% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	79.04
PEG Ratio	N/A
P/S	6.69
P/B	11.99
P/FCF	N/A
EPS Growth	+58.04%
Outstanding Shares	53.76M

Technical Indicators

50-Day SMA	$43.31
200-Day SMA	$35.56
RSI (14)	76.93
Beta	1.16
52-Week High	$49.90
52-Week Low	$13.64

Volume Today	201.87K
Avg Daily Volume (30D)	384.74K
Relative Volume	0.52x
Volatility (10D)	51.15
Volatility (30D)	46.33
Free Float	96.28%

Analyst Consensus

BUY

Current Price $48.73

Mean Target $53.22

52W Low$13.64 52W High$49.90

Current

Target

$13.64 $49.90

Current Analyst target

+9.22% upside potential · 9 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S5SRD1

ISINUS05463X1063

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 27, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.